Fingerprint
Dive into the research topics of 'NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically